https://www.benzinga.com/general/biotech/23/06/32869702/final-data-report-eloxx-touts-improved-lung-function-for-cystic-fibrosis-candidate
Final Data Report: Eloxx Touts Improved Lung Function For Cystic Fibrosis Candidate - Eloxx Pharma...
Jun 15, 2023 - Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) announced the final data assessment from the Phase 2 trial of ELX-02, the company's lead invest
https://www.eloxxpharma.com/
Home - Eloxx Pharmaceuticals
pharmaceuticals
https://www.globenewswire.com/news-release/2023/11/13/2779493/0/en/Eloxx-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-and-Operating-Results-and-Provides-Business-Update.html
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial
Kidney morphology improved in all three patients with protein re-expression consistent with disease regression in its Phase 2 open-label clinical trial of...
third quarterpharmaceuticalsreportsfinancial